Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TargeGen closes $30mm second round

Executive Summary

Less than two years after it completed its $10mm Series A financing, TargeGen (focused on cardiovascular diseases and cancer) has raised $30mm with its second round of funding. Co-led by new investors William Blair Capital Partners and CDP Capital Technology Ventures, existing backers including Forward Ventures, Enterprise Partners, and China Development Industrial Bank also joined in the round.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies